Article
Utility of ATP7B in prediction of response to platinum-based chemotherapy in urothelial bladder cancer.
Anticancer research - 1 Sept 2013
Schmid Sebastian Christoph, Schuster Tibor, Horn Thomas, Gschwend Jürgen, Treiber Uwe, Weirich Gregor
Abstract excerpt
BACKGROUND: Platinum-based chemotherapy is the treatment of choice for metastatic urothelial carcinoma, which is limited by primary and secondary resistance of the tumour. The Cu(2+) transporting beta polypeptide ATPase (ATP7B) is believed to play a role in this resistance. The aim of this study was to screen the ATP7B gene for mutations and loss of heterozygosity in bladder cancer and to evaluate their impact on...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
